home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

How A Vaccine Enhancer Works

  May, 28 2008 19:26
your information resource in human molecular genetics

For more than eighty years vaccines have been administered along with alum - an aluminium salt known as an adjuvant - because it somehow boosted the biological agent's effect in stimulating a protection response by the recipient's immune system. A paper in Nature finally reveals how this simple chemical accomplishes this remarkable feat across the board for different vaccines.

Richard Flavell and his colleagues show that aluminium adjuvants activate Nalp3, a component of the inflammasome - a system that controls the production of specific cytokines, which are crucial molecular mediators of the immune response. Nalp3 is a member of a class of cellular receptors known as NOD-like receptors that pick up on signs of cell damage - in this case, it is the insoluble aluminium particles in the adjuvant that call in the defence after the vaccine's biological agent has raised the alarm.

As the authors point out, understanding how this widely used adjuvant acts on the immune system to enhance vaccine efficacy could help in the design of more powerful, more specific adjuvants that exploit the same biochemical pathway as alum.


Richard Flavell (Yale University School of Medicine, New Haven, CT, USA)
E-mail: richard.flavell@yale.edu

Abstract available online.

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.